Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Sponsors Seek Statistical Flexibility When Reference Products Change

Dec 21 2017

• By Sue Sutter

Related Content

Interchangeable Biosimilars: FDA Clarifies US Reference Not Mandatory For Studies

Oct 27 2017

Biosimilars Statistical Guidance Reflects Early Development Approach

Sep 22 2017

Related Companies

Amgen, Inc.

Novartis AG

Novartis AG

Pfizer Inc.

Momenta Pharmaceuticals, Inc.

Additional Topics

United States Biosimilars Biologics Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window